H Lundbeck A/S - ESG Rating & Company Profile powered by AI
The assessment of H Lundbeck A/S uses intelligence from across the web and also from available disclosures by H Lundbeck A/S. Full Sustainability analysis of H Lundbeck A/S are reached by registering for free. Jump to the end of the webpage for potential risks for H Lundbeck A/S based on sector, geography and size.
H Lundbeck A/S in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | H Lundbeck A/S | 8.0 | High |
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does H Lundbeck A/S have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes H Lundbeck A/S disclose current and historical energy intensity?
Sign up for free to unlockDoes H Lundbeck A/S report the average age of the workforce?
Sign up for free to unlockDoes H Lundbeck A/S reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes H Lundbeck A/S disclose its ethnicity pay gap?
Sign up for free to unlockDoes H Lundbeck A/S disclose cybersecurity risks?
Sign up for free to unlockDoes H Lundbeck A/S offer flexible work?
Sign up for free to unlockDoes H Lundbeck A/S have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes H Lundbeck A/S disclose the number of employees in R&D functions?
Sign up for free to unlockDoes H Lundbeck A/S conduct supply chain audits?
Sign up for free to unlockDoes H Lundbeck A/S disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes H Lundbeck A/S conduct 360 degree staff reviews?
Sign up for free to unlockDoes H Lundbeck A/S disclose the individual responsible for D&I?
Sign up for free to unlockDoes H Lundbeck A/S disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes H Lundbeck A/S disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes H Lundbeck A/S disclose water use targets?
Sign up for free to unlockDoes H Lundbeck A/S have careers partnerships with academic institutions?
Sign up for free to unlockDid H Lundbeck A/S have a product recall in the last two years?
Sign up for free to unlockDoes H Lundbeck A/S disclose incidents of discrimination?
Sign up for free to unlockDoes H Lundbeck A/S allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas H Lundbeck A/S issued a profit warning in the past 24 months?
Sign up for free to unlockDoes H Lundbeck A/S disclose parental leave metrics?
Sign up for free to unlockDoes H Lundbeck A/S disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes H Lundbeck A/S disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes H Lundbeck A/S disclose the pay ratio of women to men?
Sign up for free to unlockDoes H Lundbeck A/S support suppliers with sustainability related research and development?
Sign up for free to unlockDoes H Lundbeck A/S disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes H Lundbeck A/S reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs H Lundbeck A/S involved in embryonic stem cell research?
Sign up for free to unlockDoes H Lundbeck A/S disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes H Lundbeck A/S disclose its waste policy?
Sign up for free to unlockDoes H Lundbeck A/S report according to TCFD requirements?
Sign up for free to unlockDoes H Lundbeck A/S disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes H Lundbeck A/S disclose energy use targets?
Sign up for free to unlockDoes H Lundbeck A/S disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes H Lundbeck A/S have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for H Lundbeck A/S
These potential risks are based on the size, segment and geographies of the company.
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.